Work

A multicenter blinded preclinical randomized controlled trial on Jak1/2 inhibition in MRL/MpJ-Fas mice with proliferative lupus nephritis predicts low effect size

Year: 2021

Type: article

Source: Kidney International

Authors: Yutian Lei, Bettina Sehnert, Reinhard E. Voll, Conxita Jacobs-Cachá, Maria Jose Soler, Maria D. Sanchez-Niño, Alberto Ortiz, Roman D. Bülow, Peter Boor, Hans-Joachim Anders

Institutions: LMU Klinikum, Ludwig-Maximilians-Universität München, University of Freiburg, University Medical Center Freiburg, Universitat Autònoma de Barcelona, Vall d'Hebron Institut de Recerca, Vall d'Hebron Hospital Universitari, Fundación Renal Española, Universidad Autónoma de Madrid, RWTH Aachen University

Language: English

Topic: Systemic Lupus Erythematosus Research

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Deutsche Forschungsgemeinschaft, Bundesministerium für Bildung und Forschung, China Scholarship Council, Horizon 2020

Awards: G1474430447, G1670431928, G355211206, G3663257560, G4197821126, G4208438675, G5167238611, G7095897438, G916432086

OpenAlex ID: W3131922625

FWCI: 2.349

Cites: 42

Cited by: 16

Related to: 10